| Bioactivity | 4,4′-MDI (Diphenylmethane diisocyanate) serves as a key aromatic diisocyanate monomer utilized extensively in the manufacturing of polyurethane plastics, foam insulation, coatings, adhesives, and sealants. Its high reactivity stems from the existence of two isocyanate functional groups. Renowned for its remarkable strength, durability, and resistance to chemical and environmental degradation, MDI finds applications in resin formulations, lithographic printing plates, coating films, optical films, image display devices, semiconductor devices, and the production of polyurethane foam. |
| CAS | 101-68-8 |
| Formula | C15H10N2O2 |
| Molar Mass | 250.25 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Glucosylceramide: a novel method for enhancement of natural killer T lymphoycte plasticity in murine models of immunemediated disorders [2]. Rapid nanoscale quantitative analysis of plant sphingolipid long-chain bases by GC-MS [3]. Detection of antibody against fungal glucosylceramide in immunocompromised patients: a potential new diagnostic approach for cryptococcosis [4]. Amelioration of hepatic fibrosis via betaglucosylceramide-mediated immune modulation is associated with altered CD8 and NKT lymphocyte distribution [5]. Glucocerebroside treatment ameliorates ConA hepatitis by inhibition of NKT lymphocytes [6]. Glucosylsphingosine promotes alpha-synuclein pathology in mutant GBA-associated Parkinson's disease |